CPT 83002: Luteinizing Hormone (LH) Assay, Serum
Commercial payers pay $44 on average nationally for this procedure.
CPT code 83002 describes a laboratory assay measuring luteinizing hormone (LH), a pituitary gonadotropin affecting ovulation in females and testosterone production in males; this service is a clinical laboratory endocrine assay typically performed on a serum specimen in a hospital or outpatient laboratory setting for evaluation of reproductive or endocrine function.
Customize your policy alerts
Sign up for cpt 83002 policy alerts
Get alerted when payer policies referencing 83002 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial pricing for CPT 83002 centers around a BUCA average of $43.8, with notable variation among major carriers. Blue Cross Blue Shield shows the highest mean and wide spread, while Aetna and Cigna sit closer to BUCA’s level. UnitedHealth Group’s central tendency is below BUCA. Blue Cross Blue Shield’s interquartile range (P75–P25) is $27.6 ($72.5 minus $45.3), indicating the widest middle-range dispersion; Aetna’s IQR is $12.1 ($25.8 minus $13.7), Cigna’s is $15.7 ($26.8 minus $13.1), UnitedHealth Group’s is $10.6 ($18.5 minus $8.2), and BUCA’s IQR is $18.0 ($51.6 minus $31.8).
This mix yields a market where some payers cluster tightly around mid-teens to low-$20s while others, particularly Blue Cross Blue Shield, permit substantially higher contracted rates at the upper quartile. Payors with tighter IQRs such as UnitedHealth Group suggest more concentrated negotiation outcomes, whereas Blue Cross Blue Shield’s wider IQR reflects broader variability in commercial reimbursement for this code.